Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Skyepharma PLC

+ Add to Watchlist

SKP:LN

290.000 GBp 0.0000.00%

As of 11:35:08 ET on 05/28/2015.

Snapshot for Skyepharma PLC (SKP)

Open: 289.250 Day's Range: 287.000 - 297.000 Volume: 453,323
Previous Close: 290.000 52wk Range: 229.500 - 377.500 1-Yr Rtn: +16.00%

Stock Chart for SKP

No chart data available.
  • SKP:LN 290.000
  • 1D
  • 1M
  • 1Y
290.000
Interactive SKP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SKP

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 16.4773
Relative P/E vs. UKX -
Earnings Per Share (GBP) (ttm) -0.2014
Est. EPS (GBP) (12/2015) 0.1760
Est. PEG Ratio -
Market Cap (M GBP) 303.96
Shares Outstanding (M) 104.81
30 Day Average Volume 184,040
Price/Book (mrq) 11.1748
Price/Sale (ttm) 3.2251
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SKP

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for SKP

SkyePharma plc operates a group of companies that research, develop, manufacture and market prescription pharmaceutical products. The Group's products are available in topical, oral, injectable and inhalation form.

Peter William GrantCEO/Exec DirAndrew DerodraCFO/Exec Dir
John MurphySecretary/General CounselJonathan BirtInvestor Relations
More Company Profile & Key Executives for SKP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil